USD 0.0
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | -100.0% |
2019 | 8.04 Million USD | -6.44% |
2018 | 8.6 Million USD | 14.21% |
2017 | 7.53 Million USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | -100.0% |
2007 | 23.00 USD | -96.86% |
2006 | 732.00 USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2022 FY | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2020 Q2 | 7.19 Million USD | -10.99% |
2020 FY | - USD | -100.0% |
2020 Q3 | 5.58 Million USD | -22.38% |
2020 Q1 | 8.08 Million USD | 0.47% |
2019 FY | 8.04 Million USD | -6.44% |
2019 Q2 | 21.65 Million USD | -21.09% |
2019 Q1 | 27.43 Million USD | 219.03% |
2019 Q3 | 15.09 Million USD | -30.27% |
2019 Q4 | 8.04 Million USD | -46.71% |
2018 Q4 | 8.6 Million USD | -9.64% |
2018 FY | 8.6 Million USD | 14.21% |
2018 Q2 | 9.62 Million USD | 22.34% |
2018 Q3 | 9.51 Million USD | -1.13% |
2018 Q1 | 7.86 Million USD | 4.49% |
2017 Q2 | 3.19 Million USD | 0.0% |
2017 Q4 | 7.53 Million USD | 165.66% |
2017 FY | 7.53 Million USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q3 | 2.83 Million USD | -11.4% |
2016 Q4 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 FY | - USD | -100.0% |
2008 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | -100.0% |
2007 FY | 23.00 USD | -96.86% |
2007 Q3 | 2757.00 USD | 178.77% |
2007 Q4 | 23.00 USD | -99.17% |
2007 Q1 | 128.00 USD | 0.0% |
2007 Q2 | 989.00 USD | 672.66% |
2006 FY | 732.00 USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
BioQuest Corp. | 5914.00 USD | 100.0% |
High Sierra Technologies, Inc. | 101.5 Thousand USD | 100.0% |
Instadose Pharma Corp. | - USD | NaN% |